HuiLiao Biomedical Raises RMB 100 Million in Pre-Series A Round for mRNA Development
China-based nucleic acid drug specialist Suzhou HuiLiao Biomedical Technology Co., Ltd has reportedly raised over...
InnoCare Pharma Initiates Clinical Study for BCL2 Inhibitor ICP-248 in China
China-based InnoCare Pharma (HKG: 9969, SHA: 688428) has announced the first subject dosing in a...
Thederma Pharmaceuticals Raises RMB 100 Million for AhR-Targeted Therapies
China-based Shanghai Thederma Pharmaceuticals Co., Ltd has reportedly raised RMB 100 million (USD 14.35 million)...
Xinrui Medtech Secures Pre-Series A Funding for Cardiovascular Device Development
Xinrui Medtech, a cardiovascular device maker based in Suzhou, has reportedly raised “tens of millions”...
Lifetech Scientific’s IBS Angel Stent Receives CE MDR Certification in EU
China-based Lifetech Scientific Corporation (HKG: 1302) has announced that it has received CE MDR certification...
Olipharma Raises Funds in Pre-Series A+ Round to Expand Manufacturing Facilities
Olipharma, a small nucleic acid drug Contract Development and Manufacturing Organization (CDMO) based in Suzhou,...
Inventiva and Chia Tai Tianqing File Clinical Trial for Lanifibranor with CDE
France-based Inventiva S.A. and China’s Chia Tai Tianqing have filed a clinical trial application with...
Simcere Pharmaceutical Initiates Clinical Study for Bispecific Antibody SIM0237 in Advanced Tumors
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced the first patient in (FPI) a clinical...
AusperBio and Asymchem Form Strategic Partnership for New Drug R&D and Services
China-based firms AusperBio and Asymchem (SHE: 002821, HKG: 6821) have entered into a strategic partnership...
NHSA’s 2022 Healthcare Security Report Reveals Break-Even Performance
The National Healthcare Security Administration (NHSA) has released its annual “Healthcare Security Development Statistical Bulletin”...
Bio-Thera Solutions Initiates Phase I Study for Trop2-Targeting ADC BAT8008
China-based Bio-Thera Solutions, Ltd (SHA: 688177) has announced the first patient dosing in a multi-center,...
Astellas and Seagen File for NMPA Approval of Enfortumab Vedotin for Urothelial Carcinoma
Japan-based Astellas Pharma Inc. (TYO: 4503) and US biotech Seagen Inc. (Nasdaq: SGEN) have announced...
HealiRNA Secures RMB 100 Million in Pre-Series A Funding for Nucleic Acid Drug Development
China-based nucleic acid drug specialist Suzhou HealiRNA has reportedly raised over RMB 100 million (USD...
InnoCare Pharma Initiates Clinical Study for BCL2 Inhibitor ICP-248 in China
China-based InnoCare Pharma (HKG: 9969, SHA: 688428) has announced the first subject dosing in a...
Thederma Pharmaceuticals Raises RMB 100 Million for AhR-Targeted Autoimmune Therapies
China-based Shanghai Thederma Pharmaceuticals Co., Ltd has reportedly raised RMB 100 million (USD 14.35 million)...
Xinrui Medtech Secures Pre-Series A Funding for Cardiovascular Device Development
Xinrui Medtech, a cardiovascular device maker based in Suzhou, has reportedly raised “tens of millions”...
Haihe Pharma’s Glumetinib Gains Conditional NMPA Approval for NSCLC
Shanghai Haihe Pharmaceutical Co., Ltd’s Category 1 product, glumetinib, has received conditional market approval from...
AmVision Biotech Secures Nearly $14.34M in Series A+ for Ophthalmology Innovations
AmVision Biotech, a leading ophthalmology device platform company based in Guangzhou, has reportedly secured close...
JW Therapeutics Launches Carteyva Clinical Study for High-Risk Lymphoma
China-based JW Therapeutics (HKG: 2126) has announced the initiation of a clinical study for its...
Chongqing Evaheart Secures Near $100M in Series A for Heart Failure Platform
Chongqing Evaheart Medical Device Co., Ltd has reportedly secured close to USD 100 million in...